The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System

Exclusion Criteria

• •1. \- Significant bleeding diatheses or coagulopathy
• •2. \- Planned endovascular or surgical procedures within next 30 days
• •3. \- Planned ipsilateral femoral arteriotomy within next 90 days
• •4. \- Arteriotomy in ipsilateral groin within the past 30 days with any residual hematoma, significant bruising or vascular complication
• •5. \- Previous vessel closure device used in ipsilateral groin within the past 90 days
• •6. \- Previous vascular surgery or repair in the vicinity of the target access site
• •7. \- Severe peripheral vascular disease in the ipsilateral limb requiring surgical or endovascular treatment within the pervious 30 days or next 30 days
• •8. \- Existing nerve damage in ipsilateral limb
• •9. \- Extreme morbid obesity (BMI \> 4 kg/m2)
• •10. \- Use of a procedural sheath that is \< 5 Fr or \> 7 Fr
• •11. \- Difficult insertion of procedural sheath or needle stick problems at the onset of the procedure
• •12. \- Placement of an ipsilateral venous sheath for procedure
• •13. \- Procedural sheath placement either through the superficial femoral artery and into the profunda femoris artery, or placement at or distal to bifurcation of the superficial femoral artery and the profunda femoris artery
• •14. \- In subjects receiving unfractionated heparin, an ACT \> 350 seconds, or \> 250 seconds in the presence of a GP IIb/IIIa inhibitor
• •15. \- Procedures or existing medical conditions that may extend index hospitalization beyond 24 hours post-procedure
• •16. \- Systemic hypertension (SBP \> 180 mmHg) or hypotension (SBP \< 90 mmHg) just prior to enrollment